Nifedipine NDC 68682-107

NDC codes

FDA NDC Directory

Product NDC (as listed)68682-107Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68682-0107Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68682-107-10	68682010710	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-107-10)Marketed from Aug 16, 2002

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nifedipine
Generic name (nonproprietary): nifedipine
Active ingredients: Nifedipine — 90 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Oceanside Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076070
Marketing start: Aug 16, 2002
Listing expires: Dec 31, 2027
Other FDA classes: Calcium Channel Antagonists (Mechanism)Dihydropyridines (Chemical structure)
Identifiers: Product ID 68682-107_8e94acd8-b4bb-4b2f-be6f-9783fd5e1d04SPL ID 8e94acd8-b4bb-4b2f-be6f-9783fd5e1d04SPL set ID ca5b0178-4e5f-4077-ada5-7058b0a03858RxCUI 198036UNII I9ZF7L6G2L
Pharmacologic class: Dihydropyridine Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468682010710 followed by a unit qualifier and the quantity

Package 68682-0107-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 5, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Nifedipine extended-release tablets are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076070

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076070
Product	Strength	Form · route	Labeler	Product NDC
Nifedipine	Nifedipine 90 mg/1	Tablet, Extended releaseOral	Aphena Pharma Solutions - Tennessee, LLC	71610-055
Nifedipine	Nifedipine 90 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	72162-2261